CMS is announcing changes to the Medicare Advantage Value-Based Insurance Design (MA-VBID) model, which is testing how MA plans can use health plan design elements (e.g., supplemental benefits, disease management, or reduced cost sharing) to encourage enrollees with specified chronic conditions to use high-value clinical services or high-value providers that improve quality of care while reducing costs. As previously reported, this innovation model begins its first performance year in 2017 in seven states: Arizona, Indiana, Iowa, Massachusetts, Oregon, Pennsylvania, and Tennessee. CMS recently announced that it will expand this model to Alabama, Michigan, and Texas beginning in 2018. Among other changes, CMS also will add rheumatoid arthritis and dementia to the clinical categories for which participants may offer benefits in 2018, along with the current conditions (diabetes, congestive heart failure, chronic obstructive pulmonary disease, past stroke, hypertension, coronary artery disease, and mood disorders).